IP Group Plc (IPO) 2005年年度报告「LSE」.pdf

1、www.IP2IPO.comIP2IPO Group plcWarwick Court5 Paternoster SquareLondon EC4M 7BPIP2IPO Group plc Annual Report and Accounts For the financial year ended 31 December 20052005Registered Number:4204490IP2IPO Group plc Annual Report and Accounts for the financial year ended 31 December 2005IP2IPOs busines

2、s is the generation of value from intellectual property originating from research intensive institutions.Contents01Highlights02OurUniversityPartners04 ExecutiveChairmansStatement06ChiefExecutivesStatement08BoardofDirectors10DirectorsReport11DirectorsRemunerationReport14CorporateGovernance17Independe

3、ntAuditorsReporttotheShareholdersofIP2IPOGroupplc18ConsolidatedIncomeStatement19ConsolidatedBalanceSheet20ConsolidatedCashflowStatement21ConsolidatedStatementofChangesinShareholdersEquity22NotestotheConsolidatedFinancialStatements44 CompanyBalanceSheet45NotestotheCompanyFinancialStatements47Director

4、s,SecretaryandAdvisorstotheGroupIP2IPO Group plcAnnual Report and Accounts 200501 HighlightsValue of shares in spin-outs at 31 December 2005:44 million(2004:36 million).Six university partners at 31 December 2005(2004:four).37 spin-out companies at 31 December 2005(2004:20).Successful flotation of t

5、wo portfolio companies during 2005(2004:three).Realisation from the sale of shares in spin-out companies of 0.8 million(2004:0.8 million).Profit after tax of 5.6 million(2004:21.0 million).Cash balance at 31 December 2005 of 40 million (2004:35 million).Acquisition of Techtran Group Limited in Janua

6、ry 2005.25-year partnership signed with The University of Bristol.Successful launch of Modern Biosciences plc.25-year partnership signed with The University of Surrey in February 2006.Modern Biosciences entered into a Memorandum of Understanding with the University of Manchester in March 2006.Partne